Analysis of the glucocerebrosidase gene in Parkinson's disease

被引:96
作者
Sato, C
Morgan, A
Lang, AE
Salehi-Rad, S
Kawarai, T
Meng, Y
Ray, PN
Farrer, LA
St George-Hyslop, P
Rogaeva, E
机构
[1] Univ Toronto, Dept Med, Ctr Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada
[2] Univ Toronto, Toronto Western Hosp, Movement Disorders Ctr, Toronto, ON, Canada
[3] Boston Univ, Sch Med, Boston, MA 02118 USA
[4] Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada
[5] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada
[6] Univ Hlth Network, Dept Med, Div Neurol, Toronto, ON, Canada
[7] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada
关键词
Gaucher's disease; Parkinson's disease; glucocerebrosidase; risk factors;
D O I
10.1002/mds.20319
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) is a common progressive neurodegenerative disorder characterized clinically by a combination of motor symptoms. Identifying novel PD genetic risk factors is important for understanding its pathogenesis. A recent study suggested that up to 21% of subjects with PD may have mutations in the glucocerebrosidase (GBA) gene. We investigated the GBA gene for mutations in 88 PD cases and 122 normal controls and detected the presence of heterozygous GBA mutations in 5 PD cases and in 1 control. Sequencing of the entire open reading frame of the GBA gene in a subset of 25 cases with early-onset PD (< 50 years of age) uncovered no additional mutations. Our results demonstrate a marginally significant association of GBA mutations with PD and suggest that variations in the GBA gene may constitute a rare susceptibility factor for PD (P = 0.048). (c) 2004 Movement Disorder Society.
引用
收藏
页码:367 / 370
页数:4
相关论文
共 21 条
[1]   Gaucher's disease with Parkinson's disease - Clinical and pathological aspects [J].
Bembi, B ;
Marsala, SZ ;
Sidransky, E ;
Ciana, G ;
Carrozzi, M ;
Zorzon, M ;
Martini, C ;
Gioulis, M ;
Pittis, MG ;
Capus, L .
NEUROLOGY, 2003, 61 (01) :99-101
[2]  
Beutler E, 1996, HUM MUTAT, V8, P207, DOI 10.1002/(SICI)1098-1004(1996)8:3<207::AID-HUMU2>3.3.CO
[3]  
2-5
[4]  
Beutler E., 2001, METABOLIC MOL BASES, V3, P3635
[5]   Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia [J].
Boeve, BF ;
Lang, AE ;
Litvan, I .
ANNALS OF NEUROLOGY, 2003, 54 :S15-S19
[6]   Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism [J].
Bonifati, V ;
Rizzu, P ;
van Baren, MJ ;
Schaap, O ;
Breedveld, GJ ;
Krieger, E ;
Dekker, MCJ ;
Squitieri, F ;
Ibanez, P ;
Joosse, M ;
van Dongen, JW ;
Vanacore, N ;
van Swieten, JC ;
Brice, A ;
Meco, G ;
van Duijn, CM ;
Oostra, BA ;
Heutink, P .
SCIENCE, 2003, 299 (5604) :256-259
[7]   Progressive supranuclear palsy: where are we now? [J].
Burn, DJ ;
Lee, AJ .
LANCET NEUROLOGY, 2002, 1 (06) :359-369
[8]   Molecular pathways of neurodegeneration in Parkinson's disease [J].
Dawson, TM ;
Dawson, VL .
SCIENCE, 2003, 302 (5646) :819-822
[9]   Caught in the act:: α-synuclein is the culprit in Parkinson's disease [J].
Eriksen, JL ;
Dawson, TM ;
Dickson, DW ;
Petrucelli, L .
NEURON, 2003, 40 (03) :453-456
[10]   Genetics of parkinsonism [J].
Gwinn-Hardy, K .
MOVEMENT DISORDERS, 2002, 17 (04) :645-656